Syndax Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%)等
02/14 12:53 (美东)
Syndax Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(3.3%),Point72 Capital Advisors, Inc.(3.3%)等
02/14 07:06 (美东)
Syndax Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Avidity Partners Management LP(4.7%),Avidity Partners Management (GP) LLC(4.7%)等
02/13 21:46 (美东)
Syndax Pharmaceuticals | SC 13G:超过5%持股股东披露文件-The Vanguard Group(5.11%)
02/13 17:27 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-高管 Metzger Michael A
02/09 16:12 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-高管 Goldan Keith A.
02/09 16:12 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-高管 Gallagher Neil
02/09 16:12 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Legault Pierre
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Podlesak Dennis
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Morrison Briggs
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Meury William
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Katkin Keith
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Jarrett Jennifer
02/09 16:06 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Huber Martin H. Jr.
02/09 16:06 (美东)
Syndax Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Wellington Management Group LLP(8.94%),Wellington Group Holdings LLP(8.94%)等
02/08 10:21 (美东)
Syndax Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(8.3%)
01/25 17:01 (美东)
Syndax Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(5.91%)
01/25 11:25 (美东)
Syndax Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Steven A. Cohen(5.1%),Point72 Asset Management, L.P.(4.5%)等
2023/10/31 16:26 (美东)
Syndax Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Frazier Life Sciences Public Fund, L.P.(0.0%),FHMLSP, L.P.(0.0%)等
2023/10/05 12:23 (美东)
Syndax Pharmaceuticals | 4:持股变动声明-董事 Morrison Briggs
2023/08/10 06:50 (美东)
暂无数据
暂无数据